DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
What is the competitive landscape for MYLAN PHARMS INC, and when can generic versions of MYLAN PHARMS INC drugs launch?
MYLAN PHARMS INC has two hundred and fifty-eight approved drugs.
There are eleven US patents protecting MYLAN PHARMS INC drugs. There are twenty-nine tentative approvals on MYLAN PHARMS INC drugs.
There are one hundred and ninety-one patent family members on MYLAN PHARMS INC drugs in thirty-nine countries and five hundred and five supplementary protection certificates in fourteen countries.
Summary for Mylan Pharms Inc
| International Patents: | 191 |
| US Patents: | 11 |
| Tradenames: | 212 |
| Ingredients: | 202 |
| NDAs: | 258 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 011601-006 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077550-001 | May 14, 2015 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Pharms Inc | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 091537-006 | Feb 12, 2013 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Pharms Inc | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 076540-001 | Mar 20, 2007 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Pharms Inc | ZOVIRAX | acyclovir | SUSPENSION;ORAL | 019909-001 | Dec 22, 1989 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200690-001 | Aug 1, 2012 | AB2 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ➤ Sign Up |
| Mylan Pharms Inc | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | 5,840,763 | ➤ Sign Up |
| Mylan Pharms Inc | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | 5,075,445 | ➤ Sign Up |
| Mylan Pharms Inc | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | 6,573,378 | ➤ Sign Up |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | ➤ Sign Up |
| Mylan Pharms Inc | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 7,553,835 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for MYLAN PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Foam | 0.12% | ➤ Subscribe | 2007-08-10 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Topical Foam | 0.05% | ➤ Subscribe | 2005-06-27 |
International Patents for Mylan Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Germany | 69937802 | ➤ Sign Up |
| United Kingdom | 8423833 | ➤ Sign Up |
| European Patent Office | 1872776 | ➤ Sign Up |
| European Patent Office | 1024792 | ➤ Sign Up |
| South Africa | 8507149 | ➤ Sign Up |
| New Zealand | 209248 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mylan Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2008 00035 | Denmark | ➤ Sign Up | PRODUCT NAME: SITAGLIPTIN VALGFRIT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, ISAER MONOPHOSPHAT, METFORMIN VALGFRIT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, ISAER HYDROCHLORID |
| /2004 | Austria | ➤ Sign Up | PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211 |
| 2013025,C1304992 | Lithuania | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
| 075033 | Germany | ➤ Sign Up | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| 00677 | Netherlands | ➤ Sign Up | PRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121 |
| /2006 | Austria | ➤ Sign Up | PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN; NAT. REGISTRATION NO/DATE: 1-26271, 1-26273 20060330; FIRST REGISTRATION: FR 369300.9;369301.5; 369302.1;369303.8;369304.4;369305.0; 20050707 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
